Covered recipient · General Payments record
LEWIS STOLMAN
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2024
$2,850.40
- Reported across 157 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $746.07 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $201.42 | 4 |
| ABBVIE INC. | $167.02 | 9 |
| Amgen Inc. | $148.31 | 5 |
| Incyte Corporation | $66.27 | 3 |
| Arcutis Biotherapeutics, Inc. | $47.82 | 2 |
| LEO Pharma Inc. | $44.88 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $26.89 | 1 |
| Dermavant Sciences, Inc. | $22.53 | 1 |
| PFIZER INC. | $20.93 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $29.02 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106168803 | CMS |
| ABBVIE INC. | $18.99 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106168805 | CMS |
| ABBVIE INC. | $21.96 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106168807 | CMS |
| ABBVIE INC. | $3.70 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106168809 | CMS |
| ABBVIE INC. | $27.34 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106168811 | CMS |
| ABBVIE INC. | $27.33 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106168813 | CMS |
| ABBVIE INC. | $22.11 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106168815 | CMS |
| ABBVIE INC. | $2.91 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106168817 | CMS |
| ABBVIE INC. | $13.66 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106168819 | CMS |
| Amgen Inc. | $17.35 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117392386 | CMS |
| Amgen Inc. | $12.36 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117392388 | CMS |
| Amgen Inc. | $12.93 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117392390 | CMS |
| Amgen Inc. | $17.14 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117392392 | CMS |
| Amgen Inc. | $88.53 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117392394 | CMS |
| Arcutis Biotherapeutics, Inc. | $23.49 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121060007 | CMS |
| Arcutis Biotherapeutics, Inc. | $24.33 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121060009 | CMS |
| Dermavant Sciences, Inc. | $22.53 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127939942 | CMS |
| Incyte Corporation | $23.10 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141265415 | CMS |
| Incyte Corporation | $15.12 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141310085 | CMS |
| Incyte Corporation | $28.05 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141239497 | CMS |
| LEO Pharma Inc. | $28.47 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152652931 | CMS |
| LEO Pharma Inc. | $16.41 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152652933 | CMS |
| Novartis Pharmaceuticals Corporation | $26.89 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087225081 | CMS |
| PFIZER INC. | $20.93 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131447055 | CMS |
| UCB, Inc. | $27.33 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143301395 | CMS |
| UCB, Inc. | $29.68 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143301399 | CMS |
| UCB, Inc. | $19.41 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143301404 | CMS |
| UCB, Inc. | $125.00 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143301409 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.